• Something wrong with this record ?

Endocrine Disruptors and Estrogens in Human Prostatic Tissue

J. Vitku, T. Skodova, A. Varausova, L. Gadus, L. Michnova, L. Horackova, L. Kolatorova, M. Simkova, J. Heracek

. 2023 ; 72 (S4) : S411-S422. [pub] 2023Dec17

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23022229

Endocrine disruptors (EDs) are ubiquitous substances both in the environment and everyday products that interfere with the hormonal system. Growing evidence demonstrates their adverse effects on the organism, including the reproductive system and the prostate, owing to their (anti)estrogenic or antiandrogenic effects. Since EDs can interact with steroid hormone actions on-site, understanding the levels of intraprostatic EDs in conjunction with steroids may hold particular significance. The aim of this study was to develop and validate a method for determining estrogens, various groups of EDs (bisphenols, parabens, oxybenzone and nonylphenol) and phytoestrogens in their unconjugated and conjugated forms in prostate tissue by liquid chromatography-tandem mass spectrometry, and subsequently analyze 20 human prostate tissue samples. The method enabled 20 compounds to be analyzed: estrogens (estrone, estradiol, estriol), bisphenols (bisphenol A- BPA, BPS, BPF, BPAF, BPAP, BPZ, BPP), parabens (methyl-, ethyl-, propyl-, butyl-, benzyl- paraben), oxybenzone, nonylphenol and phytoestrogens (daidzein, genistein, equol) with LLOQs between 0.017-2.86 pg/mg of tissue. The most frequently detected EDs in prostate tissues were propylparaben (conjugated and unconjugated forms in 100 % of tissues), methylparaben (unconjugated in 45 % and conjugated in 100 %), ethylparaben (unconjugated in 25 % and conjugated in 100 % BPA (unconjugated in 35 % and conjugated in 60 % and oxybenzone (both forms in 45 % To the best of our knowledge, this is the first study detecting EDs, phytoestrogens and estriol conjugate (E3C) in the prostate. E3C was the most abundant estrogen in prostatic tissue. This highlights the need for further explorations into estrogen metabolism within the prostate.

000      
00000naa a2200000 a 4500
001      
bmc23022229
003      
CZ-PrNML
005      
20250318090408.0
007      
ta
008      
240104s2023 xr f 000 0|eng||
009      
AR
035    __
$a (PubMed)38116777
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Vítků, Jana $u Institute of Endocrinology, Prague, Czech Republic. jvitku@endo.cz $7 xx0211876
245    10
$a Endocrine Disruptors and Estrogens in Human Prostatic Tissue / $c J. Vitku, T. Skodova, A. Varausova, L. Gadus, L. Michnova, L. Horackova, L. Kolatorova, M. Simkova, J. Heracek
520    9_
$a Endocrine disruptors (EDs) are ubiquitous substances both in the environment and everyday products that interfere with the hormonal system. Growing evidence demonstrates their adverse effects on the organism, including the reproductive system and the prostate, owing to their (anti)estrogenic or antiandrogenic effects. Since EDs can interact with steroid hormone actions on-site, understanding the levels of intraprostatic EDs in conjunction with steroids may hold particular significance. The aim of this study was to develop and validate a method for determining estrogens, various groups of EDs (bisphenols, parabens, oxybenzone and nonylphenol) and phytoestrogens in their unconjugated and conjugated forms in prostate tissue by liquid chromatography-tandem mass spectrometry, and subsequently analyze 20 human prostate tissue samples. The method enabled 20 compounds to be analyzed: estrogens (estrone, estradiol, estriol), bisphenols (bisphenol A- BPA, BPS, BPF, BPAF, BPAP, BPZ, BPP), parabens (methyl-, ethyl-, propyl-, butyl-, benzyl- paraben), oxybenzone, nonylphenol and phytoestrogens (daidzein, genistein, equol) with LLOQs between 0.017-2.86 pg/mg of tissue. The most frequently detected EDs in prostate tissues were propylparaben (conjugated and unconjugated forms in 100 % of tissues), methylparaben (unconjugated in 45 % and conjugated in 100 %), ethylparaben (unconjugated in 25 % and conjugated in 100 % BPA (unconjugated in 35 % and conjugated in 60 % and oxybenzone (both forms in 45 % To the best of our knowledge, this is the first study detecting EDs, phytoestrogens and estriol conjugate (E3C) in the prostate. E3C was the most abundant estrogen in prostatic tissue. This highlights the need for further explorations into estrogen metabolism within the prostate.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    12
$a estrogeny $7 D004967
650    _2
$a parabeny $7 D010226
650    12
$a endokrinní disruptory $7 D052244
650    _2
$a prostata $x chemie $7 D011467
650    _2
$a fytoestrogeny $7 D048789
650    _2
$a estriol $7 D004964
650    _2
$a benzhydrylové sloučeniny $7 D001559
655    _2
$a časopisecké články $7 D016428
700    1_
$a Škodová, Tereza $7 _AN099705 $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Varausová, Anežka $7 xx0330058 $u Institute of Endocrinology, Department of Steroids and Proteofactors, Prague, Czech Republic
700    1_
$a Gaduš, Lukáš $7 xx0265048 $u Military University Hospital Prague, Department of Urology, Prague, Czech Republic $u Charles University, First Faculty of Medicine, Department of Urology, Prague, Czech Republic
700    1_
$a Michnová, Ľudmila $7 xx0276013 $u Military University Hospital Prague, Department of Pathology, Prague, Czech Republi
700    1_
$a Horáčková, Lenka $7 xx0264112 $u Institute of Endocrinology, Department of Steroids and Proteofactors, Prague, Czech Republic
700    1_
$a Kolátorová Sosvorová, Lucie $7 xx0140729 $u Institute of Endocrinology, Department of Steroids and Proteofactors, Prague, Czech Republic
700    1_
$a Šimková, Markéta $7 xx0232958 $u Institute of Endocrinology, Department of Steroids and Proteofactors, Prague, Czech Republic
700    1_
$a Heráček, Jiří, $d 1969- $7 nlk20050170272 $u Military University Hospital Prague, Department of Urology, Prague, Czech Republic $u Charles University, First Faculty of Medicine, Department of Urology, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, Suppl. 4 (2023), s. S411-S422
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38116777 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20240104 $b ABA008
991    __
$a 20250318090405 $b ABA008
999    __
$a ok $b bmc $g 2283442 $s 1208673
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c S4 $d S411-S422 $e 2023Dec17 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$b NLK124 $a Pubmed-20240104

Find record

Citation metrics

Archiving options